Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
13.93
+0.03 (0.22%)
Apr 29, 2026, 3:04 PM CST

SHE:002907 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
274.34456.55437.56503.53429.97
Short-Term Investments
-30.3550--
Trading Asset Securities
351.22120.61--80.61
Cash & Short-Term Investments
625.55607.51487.56503.53510.58
Cash Growth
2.97%24.60%-3.17%-1.38%-3.93%
Accounts Receivable
287.5272.7245.46315.03238.5
Other Receivables
3.873.064.249.64.33
Receivables
291.37275.76249.71324.63242.83
Inventory
139.03140.13151.68114.76127.44
Other Current Assets
72.97.955.6914.0313.25
Total Current Assets
1,1291,031894.64956.95894.1
Property, Plant & Equipment
492.68537.74593.41621.94654.21
Long-Term Investments
72.4193.6598.3984.4857.05
Other Intangible Assets
209.39125.89107.1475.2676.79
Long-Term Deferred Tax Assets
19.7217.2615.6918.6616.96
Long-Term Deferred Charges
33.0436.9760.9644.0124.89
Other Long-Term Assets
71.0774.781.2365.3747.48
Total Assets
2,0271,9181,8511,8671,771
Accounts Payable
69.5664.3655.2348.0476.1
Accrued Expenses
27.8332.329.4440.2926.94
Current Portion of Long-Term Debt
38.79----
Current Portion of Leases
-0.090.140.110.13
Current Income Taxes Payable
13.494.620.761.970.18
Current Unearned Revenue
10.069.745.696.734.35
Other Current Liabilities
104.72100.9397.41114.1899.27
Total Current Liabilities
264.44212.03188.68211.32206.97
Long-Term Debt
----250.92
Long-Term Leases
30.040.140.060.08
Long-Term Unearned Revenue
37.5542.9943.0343.5946.33
Long-Term Deferred Tax Liabilities
14.982.481.681.31.27
Total Liabilities
319.97257.55233.53256.28505.56
Common Stock
417.6417.6417.6417.6401.69
Additional Paid-In Capital
461.46459.33458.73454.72129.12
Retained Earnings
812.48782.89741.66738.19659.79
Treasury Stock
-----6.55
Comprehensive Income & Other
-0.220.18-0.07-0.1181.87
Total Common Equity
1,6911,6601,6181,6101,266
Minority Interest
15.87----
Shareholders' Equity
1,7071,6601,6181,6101,266
Total Liabilities & Equity
2,0271,9181,8511,8671,771
Total Debt
41.790.130.280.17251.12
Net Cash (Debt)
583.76607.39487.28503.36259.45
Net Cash Growth
-3.89%24.65%-3.19%94.01%-8.68%
Net Cash Per Share
1.401.451.171.250.65
Filing Date Shares Outstanding
417.13417.6417.6417.6401.71
Total Common Shares Outstanding
417.13417.6417.6417.6401.69
Working Capital
864.4819.31705.96745.63687.13
Book Value Per Share
4.053.983.873.863.15
Tangible Book Value
1,4821,5341,5111,5351,189
Tangible Book Value Per Share
3.553.673.623.682.96
Buildings
-310.3310.25297.72292.53
Machinery
-598.97582.48566.85536.22
Construction In Progress
-10.1925.7817.5223.55
Source: S&P Global Market Intelligence. Standard template. Financial Sources.